Skip to main content
. 2023 Dec 5;13:1290791. doi: 10.3389/fonc.2023.1290791

Table 2.

Parameter differences between alive and dead patients.

Characteristics Alive(n=31) Dead(n=19) P
Age (year) 54(27-81) 70(48-88) 0.003
Sex 0.077
Female 13 9
Male 18 10
TAP (μm2) 185.15(108.42-381) 229(136-402) 0.064
Tumor biomarkers 0.041
Positive 15 15
Negative 16 4
Smoking 0.722
Yes 7 3
No 24 16
Alcohol drinking 1
Yes 5 3
No 26 16
Family history of cancer 1
Yes 1 1
No 30 18
HB (×109/L) 133(72-167) 101(62-127) <0.001
WBC (×109/L) 6.4(3.8-10.2) 7.7(3-14.3) 0.171
PLT (×109/L) 248(139-531) 196(129-453) 0.299
ALT (U/L) 15(6-200) 14(6-338) 0.787
AST (U/L) 18(11-174) 22(10-389) 0.441
Scr (μmoI/L) 62(39-94) 53(40-106) 0.055
TC (mmol/L) 4.41(2.54-7.36) 4.15(1.92-6.54) 0.385
TG (mmol/L) 1.12(0.35-3.65) 1.35(0.68-8.67) 0.144
K (mmol/L) 3.93(2.79-4.47) 4.2(2.81-4.98) 0.219
Na (mmol/L) 141.3(137.8-145.3) 138.9(124.3-147.4) 0.002

TAP, tumor abnormal protein; HB, hemoglobin; WBC, white blood cell; PLT, platelet; ALT, alanine transaminase; AST, aspartate transaminase; Scr, serum creatinine; TC, total cholesterol; TG, triglyceride; K, serum potassium; Na, serum sodium.